Multi District Litigation

MDL 3026

In Re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation
- Chief Judge Rebecca R. Pallmeyer

MDL 3026
In Re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation
- Chief Judge Rebecca R. Pallmeyer


IF YOU HAVE A PACER ACCOUNT CLICK THE CONTINUE BUTTON BELOW TO LOGIN AND VIEW THE MASTER CASE FILE FOR MDL NO. 3026.


Pursuant to Judicial Conference of the United States policy, access to all case-related documents must be through the PACER system.

Public Access to Court Electronic Records (PACER) is a service that allows users to obtain case and docket information from federal appellate, district and bankruptcy courts, and the PACER Case Locator via the Internet.

PACER users must register for an account. Access to court documents costs $0.10 per page. The cost to access a single document is capped at $3.00, the equivalent of 30 pages. The cap does not apply to name searches, reports that are not case-specific and transcripts of federal court proceedings. If your usage does not exceed $15 in a quarter, fees for that quarter are waived, effectively making PACER free for most users. PACER is provided by the federal judiciary in keeping with its commitment to providing public access to court information via a centralized service.

Please note there may be a 24-hour delay from the time of filing until the document is available on the PACER System.

Close

  Master Case File MDL No. 3026


 MEMORANDUM Opinion and Order

06/23/2022

134

ENTER MEMORANDUM Opinion and Order Signed by the Honorable Rebecca R. Pallmeyer on 6/23/2022.Mailed notice(mjc, ) (Entered: 06/23/2022)
08/22/2022

191

MEMORANDUM Opinion and Order: Signed by the Honorable Rebecca R. Pallmeyer on 8/22/2022. Mailed notice. (cp, ) (Entered: 08/22/2022)
08/29/2022

207

MEMORANDUM Opinion and Order: Signed by the Honorable Rebecca R. Pallmeyer on 8/29/2022. Mailed notice.(cp, ) (Entered: 08/29/2022)
10/12/2022

252

MEMORANDUM Opinion and Order: For the foregoing reasons in the Memorandum Opinion and Order, Plaintiffs' motions to remand are granted. Signed by the Honorable Rebecca R. Pallmeyer on 10/12/2022. Mailed notice. (cp, ) (Entered: 10/13/2022)
10/12/2022

253

ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 10/12/2022. Mailed notice. (cp, ) (Entered: 10/13/2022)
07/17/2023

376

MEMORANDUM Opinion and Order regarding 22 C 3737: Signed by the Honorable Rebecca R. Pallmeyer on 7/17/2023. Mailed notice. (cp, ) (Entered: 07/17/2023)
07/17/2023

377

MEMORANDUM Opinion and Order relating to 22 C 5356: Signed by the Honorable Rebecca R. Pallmeyer on 7/17/2023. Mailed notice. (cp, ) (Entered: 07/17/2023)


 Lead Counsel List

PLAINTIFFS’ COUNSEL

Plaintiffs’ Co-Lead Counsel 
Timothy J. Becker
C. Andrew Childers
Wendy R. Fleishman
José M. Rojas
Diandra “Fu” Debrosse Zimmermann

Plaintiffs’ Executive Committee
David P. Matthews
James R. Ronca
Matthew J. Sill
Ashlie Case Sletvold
Diane K. Watkins

Plaintiffs’ Steering Committee
Russell T. Abney
Annesley DeGaris
Gerald J. Diaz, Jr.
Deborah S. Dixon
James R. Dugan, II
Kelly Hyman
Kristine K. Kraft
Noah C. Lauricella
Christopher T. Nace
Ellen A. Presby
Stephen Reck
Pearl A. Robertson
John F. Romano
James M. Williams
Jeffrey A. Bowersox

Plaintiffs’ Liaison Counsel
Elizabeth A. Kaveny


DEFENDANT’S LEAD COUNSEL

Abbott’s Lead Counsel
Stephanie E. Parker

Abbott’s Co-Liaison Counsel
Meir Feder
Bridget K. O’Connor

Mead Johnson’s Lead Counsel
Rachel Cannon

Mead Johnson’s Co-Liaison Counsel
Darlene Alt
William Andrichik


 Frequently Asked Questions

FREQUENTLY ASKED QUESTIONS

What is multidistrict litigation?

Multidistrict litigation is litigation pending in more than one federal district court involving common questions of fact. When such cases involve civil actions, they may be transferred by the Judicial Panel on Multidistrict Litigation (The Panel) to any federal court for coordinated and consolidated pretrial proceedings.

What is the Panel on multidistrict litigation?

The panel is a group of seven federal judges designated by the Chief Justice of the United States. The Panel has the responsibility for determining which cases qualify for multidistrict litigation treatment, as well as which district court to transfer and consolidate these cases. The transfers are made pursuant to 28 U.S.C. §1407, upon the Panel's determination that the transfers will result in the convenience of the parties and witnesses and will promote the just and efficient conduct of the cases.

How are the cases to be transferred brought before the Panel?

Proceedings for transfer may be initiated by the Judicial Panel on Multidistrict Litigation upon its own initiative or a motion filed with the Panel by a party in any action in which transfer for coordinated or consolidated pretrial proceedings may be appropriate. Before cases are designated multidistrict litigation and transferred to one federal court, the Panel convenes a hearing and notifies all parties of the place and time of the hearing. The Panel's order of transfer is based on a record of such hearing at which material evidence may be offered by any party to an action in any federal court that would be affected by the transfer.

If my case is subject to a transfer order, but the case has not yet been transferred to the Northern District of Illinois, where should I file documents?

Transfers under 28 U.S.C. §1407 become effective with the filing of the Panel's transfer order in the clerk's office of the designated transferee court. Thus, if the transfer order to which your case is subject has been filed in the Northern District of Illinois, you must make all future filings in the Northern District of Illinois.

Does the Court permit direct filing of cases in the Northern District of Illinois when venue is in another district?

To be determined.

Do I need to file a motion in the Northern District of Illinois to appear pro hac vice or do I need to associate local counsel?

Pro hac vice requirements (and the payment of associated fees) are waived for any attorney who has filed an appearance in a transferor court. Attorneys admitted to practice and in good standing in any United States District Court may be admitted pro hac vice in this litigation without the payment of the pro hac vice fee and without associating with local counsel. Whether or not they file appearances in this case, all lawyers in this litigation are expected to comply with the Court's Local Rules and to abide by the terms of the case management orders and protective orders.

Are attorneys in this MDL required to be e-filers in the Northern District of Illinois?

Yes. Any attorney who will participate actively in the litigation and wishes to receive copies of court filings must file an appearance in this Court and register as an e-filer, receiving training, if he/she is not registered as an e-filer in this Court or another federal court. See General Order 16-0020.

Are there any special procedures regarding service?

__________________has been authorized to accept service of Summons and Complaint on behalf of any defendants pursuant to Fed R. Civ. P. 4(d). See Case Management Order No. 1 (34)

Is there a form complaint that should be filed?

Do I need to submit courtesy copies of all electronic filings?

According to the Fifth Amended General Order, courtesy copies are no longer required and motions shall not be noticed for presentment. Parties shall propose a briefing schedule on opposed motions by joint submission to the court.

 How can I be kept advised of the developments of this case?

Court orders, developments, and upcoming events will be posted on the Court's website.

https://www.ilnd.uscourts.gov/

How can I access the docket sheet?

You may access the docket sheet online by purchasing a PACER account through the PACER Service Center's website at http://www.pacer.uscourts.gov .

Does the Court permit telephone participation at status conferences?

Yes, in some instances.



 Court Contacts

COURT CONTACTS

Chief Judge Rebecca R. Pallmeyer, U.S. District Judge
https://www.ilnd.uscourts.gov/judge-info.aspx?X0KFz5VBiGM=

Courthouse Address
219 South Dearborn Street
Chicago, Illinois  60604

Courtroom Deputy
Christina Presslak
(312) 435-5637
Room 2528A
Email: Christina_Presslak@ilnd.uscourts.gov

Judicial Assistant
Susan Kelly Lenburg
(312) 435-5600
Room 2548
Email: Susan_Lenburg@ilnd.uscourts.gov

Court Reporter
Frances Ward
(312) 435-5561
Room 2524A
Email: Frances_Ward@ilnd.uscourts.gov
Order Transcript: wardofficialtranscripts@gmail.com

Please note that Ms. Ward will not respond immediately to orders for transcripts as she is in court most of the day. If you order a transcript, you may assume that she is preparing it and will contact you when your transcript is complete and ready for pick-up.


 Member Cases

Case #PlaintiffDefendantOrig. District Case #Originating DistrictDate Closed
1:22-cv-00071HallAbbott Laboratories
1:22-cv-00192RinehartAbbott Laboratories
1:22-cv-00197GshwendAbbott Laboratories
1:22-cv-00203TaylorAbbott Laboratories
1:22-cv-00204StuperAbbott Laboratories06/23/2022
1:22-cv-00232MarAbbott Laboratories
1:22-cv-00239RhodesAbbott Laboratories
1:22-cv-00363GrosshueschMead Johnson & Company, LLC
1:22-cv-00561ShindelAbbott Laboratories
1:22-cv-01089De Los SantosAbbott Laboratories
1:22-cv-01197DevineAbbott Laboratories, Inc.07/22/2022
1:22-cv-01439FelicianoAbbott Laboratories, Inc.
1:22-cv-01951CresapAbbott Laboratories
1:22-cv-01987RichardsonAbbott Laboratories, Inc.
1:22-cv-01989DavisAbbott Laboratories, Inc.
1:22-cv-01991KeltonAbbott Laboratories, Inc.
1:22-cv-01994LittlesAbbott Laboratories, Inc.
1:22-cv-01995HunteAbbott Laboratories, Inc.
1:22-cv-01996GeorgeAbbott Laboratories, Inc.
1:22-cv-01997Sanchez JuanAbbott Laboratories, Inc.
1:22-cv-01998CrawfordMead Johnson & Company
1:22-cv-02001BrownAbbott Laboratories, Inc.
1:22-cv-02002ChildsAbbott Laboratories09/19/2022
1:22-cv-02003PerkinsAbbott Laboratories, Inc.09/19/2022
1:22-cv-02004WalkerAbbott Laboratories, Inc.09/19/2022
1:22-cv-02005AdamsAbbott Laboratories09/19/2022
1:22-cv-02006ClarkeAbbott Laboratories
1:22-cv-02007OsmunAbbott Laboratories
1:22-cv-02008BookhartAbbott Laboratories, Inc.
1:22-cv-02010LincolnAbbott Laboratories, Inc.09/19/2022
1:22-cv-02011R.J.Mead Johnson & Company, LLC
1:22-cv-02013HughesAbbott Laboratories, Inc.01/18/2023
1:22-cv-02014PostonAbbott Laboratories, Inc.
1:22-cv-02015SilversAbbott Laboratories, Inc.09/19/2022
1:22-cv-02016MedleyAbbott Laboratories, Inc.06/30/2023
1:22-cv-02017KoethMead Johnson & Company, LLC.
1:22-cv-02018McKinnonMead Johnson & Company, LLC
1:22-cv-02019PayneAbbott Laboratories
1:22-cv-02022CervantesMead Johnson & Company LLC11/10/2022
1:22-cv-02081AcostaAbbott Laboratories09/19/2022
1:22-cv-02202WilliamsMead Johnson & Company, LLC09/19/2022
1:22-cv-02203MoiseMead Johnson & Company, LLC09/19/2022
1:22-cv-02206HighsmithMead Johnson & Company, LLC
1:22-cv-02222JacobsAbbott Laboratories, Inc.
1:22-cv-02257M. R.Mead Johnson & Company, LLC
1:22-cv-02300DeleonMead Johnson & Company LLC11/10/2022
1:22-cv-02498GoalAbbott Laboratories09/19/2022
1:22-cv-02510Nancy Doty, Inc.Abbott Laboratories
1:22-cv-02511AbdullahMead Johnson & Company10/14/2022
1:22-cv-02513DraytonMead Johnson & Company, LLC10/14/2022
1:22-cv-02515StillsMead Johnson & Company, LLC10/14/2022
1:22-cv-02516CarterMead Johnson & Company, LLC10/14/2022
1:22-cv-02517TaylorMead Johnson & Company, LLC10/14/2022
1:22-cv-02518WeigerMead Johnson & Company, LLC10/14/2022
1:22-cv-02519WiegerMead Johnson & Company, LLC10/14/2022
1:22-cv-02553Pinckney-WhiteAbbott Laboratories Inc.
1:22-cv-02569SmithAbbott Laboratories, Inc.
1:22-cv-02610MeltonAbbott Laboratories Inc.10/12/2022
1:22-cv-02611Henderson Mead Johnson & Company, LLC10/14/2022
1:22-cv-02612HInesMead Johnson & Company, LLC10/14/2022
1:22-cv-02613JOHNSONMEAD JOHNSON & COMPANY, LLC10/14/2022
1:22-cv-02614McMillianMead Johnson & Company, LLC10/14/2022
1:22-cv-02615Moment Mead Johnson & Company LLC10/14/2022
1:22-cv-02616Walker-SavageAbbott Laboratories10/14/2022
1:22-cv-02617SandersMead Johnson & Company LLC10/14/2022
1:22-cv-02618ShortMead Johnson & Company, LLC10/14/2022
1:22-cv-02619WhitfieldMead Johnson & Company, LLC et al10/14/2022
1:22-cv-02620ThomasMead Johnson & Company LLC10/14/2022
1:22-cv-02621WilliamsMead Johnson & Company, LLC10/14/2022
1:22-cv-02623WitherspoonMead Johnson & Company, LLC10/14/2022
1:22-cv-02712GoodmondMead Johnson & Company, LLC10/14/2022
1:22-cv-02713GoodmondMead Johnson & Company, LLC10/14/2022
1:22-cv-02714GrayMead Johnson & Company, LLC10/14/2022
1:22-cv-02716KajuffaMead Johnson & Company LLC10/14/2022
1:22-cv-02719MaysMead Johnson & Company LLC10/14/2022
1:22-cv-02720PadillaMead Johnson & Company, LLC10/14/2022
1:22-cv-02729HumphreysAbbott Laboratories09/15/2022
1:22-cv-02760ParkerMead Parker Johnson & Company, LLC10/14/2022
1:22-cv-02761RossMead Johnson & Company, LLC10/14/2022
1:22-cv-02762WigginsMead Johnson & Company, LLC10/14/2022
1:22-cv-02763WatsonMead Johnson & Company, LLC et al10/14/2022
1:22-cv-02829HammannAbbott Laboratories, Inc.04/21/2023
1:22-cv-02891AndradeAbbott Laboratories, Inc.
1:22-cv-02893SmithAbbott Laboratories, Inc.
1:22-cv-02895Chazmine Lindsey and Bernard FoleyAbbott Laboratories
1:22-cv-02896Lambert-EllisAbbott Laboratories, Inc.
1:22-cv-02897BembryAbbott Laboratories Inc
1:22-cv-02898LeakAbbott Laboratories Inc
1:22-cv-03016Chazmine Lindsey and Bernard FoleyAbbott Laboratories
1:22-cv-03054ThomasAbbott Laboratories Inc.
1:22-cv-03055HiattAbbott Laboratories Inc
1:22-cv-03056KahanAbbott Laboratories, Inc.
1:22-cv-03057MejiaAbbott Laboratories, Inc.
1:22-cv-03136DensonMead Johnson & Company, LLC06/17/2022
1:22-cv-03152LollarMead Johnson & Company, LLC
1:22-cv-03325LopezAbbott Laboratories, Inc.
1:22-cv-03589VickersMead Johnson & Company, LLC10/21/2022
1:22-cv-03590HarrellAbbott Laboratories08/31/2022
1:22-cv-03591Patton-AshleyAbbott Laboratories, Inc.03/16/2023
1:22-cv-03649HughesAbbott Laboratories
1:22-cv-03737InmanMead Johnson & Company, LLC
1:22-cv-03794McCarthyAbbott Laboratories, Inc.
1:22-cv-03807HagermanAbbott Laboratories
1:22-cv-04115ParianiMead Johnson & Company, LLC08/31/2022
1:22-cv-04116LafondMead Johnson & Company, LLC08/31/2022
1:22-cv-04117ThomasMead Johnson & Company, LLC08/31/2022
1:22-cv-04118TracyMead Johnson & Company, LLC08/31/2022
1:22-cv-04120HartwickMead Johnson & Company, LLC08/31/2022
1:22-cv-04179AlexanderMead Johnson & Company, LLC
1:22-cv-04316DeJesusAbbott Laboratories10/17/2022
1:22-cv-04318MeierAbbott Laboratories
1:22-cv-04616AnthonyAbbott Laboratories, Inc.
1:22-cv-04849ChapinAbbott Laboratories
1:22-cv-04853ChobirkoAbbott Laboratories
1:22-cv-05029J.N.Abbott Laboratories, Inc.
1:22-cv-05033WilliamsAbbott Laboratories
1:22-cv-05044WalkerMead Johnson & Company, LLC
1:22-cv-05045WillisAbbott Laboratories
1:22-cv-05048CashAbbott Laboratories, Inc.
1:22-cv-05053K.M.Abbott Laboratories, Inc.
1:22-cv-05059DelpilarAbbott Laboratories
1:22-cv-05061SinclairAbbott Laboratories, Inc.
1:22-cv-05062IzziAbbott Laboratories
1:22-cv-05064EscobarAbbott Laboratories Inc.
1:22-cv-05169BushAbbott Laboratories
1:22-cv-05355OdomAbbott Laboratories
1:22-cv-05356DiggsAbbott Laboratories
1:22-cv-05365GippAbbott Laboratories
1:22-cv-05623PitreMead Johnson & Company, LLC
1:22-cv-05626CornwellAbbott Laboratories
1:22-cv-05627HillMead Johnson & Co LLC
1:22-cv-05639GoalAbbott Laboratories
1:22-cv-05735BrownAbbott Laboratories
1:22-cv-05812BonnerAbbott Laboratories
1:22-cv-05813GilliamMead Johnson & Company LLC
1:22-cv-05816PaulAbbott Laboratories
1:22-cv-05982PeeblesMead Johnson & Company, LLC
1:22-cv-05984StewartMead Johnson & Company, LLC
1:22-cv-06027MoyeAbbott Laboratories
1:22-cv-06405E.M.Mead Johnson & Company, LLC
1:22-cv-06594KeaneAbbott Laboratories
1:22-cv-06623TurnerAbbott Laboratories
1:22-cv-06673GrandersonAbbott Laboratories
1:22-cv-06898KortusAbbott Laboratories
1:22-cv-06909GonzalesMead Johnson & Company, LLC
1:22-cv-06914RoddyAbbott Laboratories
1:22-cv-07084CarterAbbott Laboratories
1:22-cv-07085LiddellAbbott Laboratories
1:22-cv-07086CatheyAbbott Laboratories
1:22-cv-07123LockmanAbbott Laboratories
1:22-cv-07130MillerMead Johnson & Company, LLC
1:22-cv-07229BakerAbbott Laboratories Inc
1:22-cv-07302SheppardAbbott Laboratories Inc.
1:22-cv-07303TorresAbbott Laboratories, et. al.
1:22-cv-07342EmilcaMead Johnson & Company, LLC
1:23-cv-00038SimsLaboratories
1:23-cv-00153LewisAbbott Laboratories
1:23-cv-00154CoffmanMead Johnson and Company
1:23-cv-00200CrossAbbott Laboratories
1:23-cv-00209KeyAbbott Laboratories
1:23-cv-00229W.C.Mead Johnson & Company, LLC
1:23-cv-00263PalmatureMead Johnson & Company, LLC
1:23-cv-00294PhamAbbott Laboratories
1:23-cv-00316CervantesAbbott Laboratories, Inc.
1:23-cv-00323FirlitAbbott Laboratories
1:23-cv-00324DeleonAbbott Laboratories, Inc.
1:23-cv-00331KendallAbbott Laboratories, Inc.
1:23-cv-00351HAHNMEAD JOHNSON & COMPANY, LLC
1:23-cv-00481LucasMead Johnson & Company, LLC
1:23-cv-00550SinghAbbott Laboratories
1:23-cv-00551NazzaroAbbott Laboratories, Inc.
1:23-cv-00581MasonAbbott Laboratories, INC
1:23-cv-00671WyattMead Johnson & Company, LLC
1:23-cv-00990AustinAbbott Laboratories
1:23-cv-00992ZapataMead Johnson & Company, LLC
1:23-cv-01126WallaceLaboratories
1:23-cv-01156RoweAbbott Laboratories
1:23-cv-01161SilversAbbott Laboratories
1:23-cv-01191JohnsonAbbott Laboratories
1:23-cv-01249SmithMead Johnson Laboratories
1:23-cv-01252BrownAbbott Laboratories
1:23-cv-01259CummingMead Johnson & Company, LLC
1:23-cv-01306NesheimMead Johnson & Co. LLC
1:23-cv-01412HammannAbbott Laboratories
1:23-cv-01422E.D.Abbott Laboratories, Inc.
1:23-cv-01491Lincoln, Individually and as Mother and General GuAbbott Laboratories
1:23-cv-01547JeffersonAbbott Laboratories
1:23-cv-01549DryeAbbott Laboratories
1:23-cv-01550RamseyAbbott Laboratories Inc
1:23-cv-01555JosephMead Johnson & Company, LLC
1:23-cv-01556MarcelMead Johnson & Company, LLC
1:23-cv-01642CoulombeAbbott Laboratories
1:23-cv-01643RunyonMead Johnson & Company, LLC
1:23-cv-01648ScrbacicAbbott Laboratories, Inc.
1:23-cv-01770HernandezMead Johnson & Company, LLC et al
1:23-cv-01776SYKESMEAD JOHNSON & COMPANY, LLC
1:23-cv-01785GammageAbbott Laboratories
1:23-cv-01816StevensonMead Johnson & Company, LLC
1:23-cv-01830SanchezMead Johnson & Company, LLC
1:23-cv-01831PersleyMead Johnson & Company LLC
1:23-cv-01832VillaroelMead Johnson & Company LLC
1:23-cv-01833GaydenMead Johnson & Company LLC
1:23-cv-01857BarlowMead Johnson & Company, LLC
1:23-cv-01860CamachoMead Johnson & Company, LLC
1:23-cv-01869JohnsonMead Johnson & Company LLC
1:23-cv-01871TaylorMead Johnson & Company LLC
1:23-cv-01872WilderMead Johnson & Company LLC
1:23-cv-01873BonnerMead Johnson & Company LLC
1:23-cv-01881DumasMead Johnson & Company, LLC
1:23-cv-01882WoodruffMead Johnson & Company, LLC
1:23-cv-01908PeerAbbott Laboratories
1:23-cv-01919JohnsonAbbott Laboratories
1:23-cv-01928UmezuAbbott Laboratories, Inc.
1:23-cv-01937McIntyreAbbott Laboratories
1:23-cv-01966MyersMead Johnson & Company, LLC
1:23-cv-01968JonesMead Johnson & Company LLC
1:23-cv-01973MitchellMead Johnson & Company LLC
1:23-cv-01974ThorpeMead Johnson & Company, LLC
1:23-cv-01976TurenneMead Johnson & Company LLC
1:23-cv-01979BrownMead Johnson & Company LLC
1:23-cv-01986BrunsonMead Johnson & Company LLC
1:23-cv-02068HesterMead Johnson Laboratories
1:23-cv-02077VelascoMead Johnson & Company, LLC
1:23-cv-02078CheramieMead Johnson & Company, LLC
1:23-cv-02104ZisaAbbott Laboratories
1:23-cv-02224De RuvoAbbott Laboratories
1:23-cv-02269LamendolaAbbott Laboratories
1:23-cv-02352Berry-BaptisteAbbott Laboratories Inc.
1:23-cv-02353McGinnisAbbott Laboratories Inc.
1:23-cv-02385CloveyAbbott Laboratories
1:23-cv-02496GendronAbbott Laboratories
1:23-cv-02505LaneAbbott Laboratories
1:23-cv-02507WoodsAbbott Laboratories
1:23-cv-02510ClarkMead Johnson & Company LLC
1:23-cv-02574FriedbauerMead Johnson Laboratories
1:23-cv-02584ValerioAbbott Laboratories
1:23-cv-02613DicksMead Johnson Laboratories
1:23-cv-02633TurnerMEAD JOHNSON & COMPANY, LLC
1:23-cv-02773MaldonadoAbbott Laboratories
1:23-cv-02914LeachMead Johnson Laboratories, Inc.
1:23-cv-03022SkowAbbott Laboratories
1:23-cv-03121GehringMead Johnson & Company, LLC
1:23-cv-03168OmalleyMead Johnson & Company, LLC
1:23-cv-03310RoccoAbbott Laboratories
1:23-cv-03386HoganAbbott Laboratories
1:23-cv-03388JonesMead Johnson & Company, LLC
1:23-cv-03396WallaceAbbott Laboratories
1:23-cv-03464C.B. by and through her natural mother and guardiaAbbott Laboratories
1:23-cv-03543A.H. by and through his natural mother and guardiaAbbott Laboratories
1:23-cv-03546HaynesAbbott Laboratories, Inc.
1:23-cv-03548NativiAbbott Laboratories
1:23-cv-03559HayesMead Johnson & Company LLC
1:23-cv-03636FordhamAbbott Laboratories
1:23-cv-03722ClarkAbbott Laboratories, Inc.
1:23-cv-03839YrachetaMead Johnson and Company LLC
1:23-cv-04107BarberAbbott Laboratories, Inc.
1:23-cv-04144WrightAbbott Laboratories
1:23-cv-04199C.G.Mead Johnson & Company, LLC
1:23-cv-04208ZinnAbbott Laboratories
1:23-cv-04247WalkerAbbott Laboratories
1:23-cv-04390ThomasAbbott Laboratories
1:23-cv-04394PrietoAbbott Laboratories
1:23-cv-04464KiyonoAbbott Laboratories
1:23-cv-04577CooperAbbott Laboratories
1:23-cv-04615M.L-R.Mead Johnson & Company, LLC
1:23-cv-04691JohnsonAbbott Laboratories, Inc.
1:23-cv-04766FrenchMead Johnson & Company
1:23-cv-04776RosserMead Johnson & Company, LLC
1:23-cv-04886BillsAbbott Laboratories
1:23-cv-04923JonesAbbott Laboratories
1:23-cv-05001MasonAbbott Laboratories
1:23-cv-05043DugasMead Johnson & Company, LLC
1:23-cv-05111Swears, Jr.Abbott Laboratories
1:23-cv-05114Lopez GalvanAbbott Laboratories
1:23-cv-05128BrewtonAbbott Laboratories
1:23-cv-05129ThompsonAbbott Laboratories, Inc.
1:23-cv-05209BalesAbbott Laboratories
1:23-cv-05237RiveraAbbott Laboratories
1:23-cv-05330RoseAbbott Laboratories
1:23-cv-05349MartinezAbbott Laboratories, Inc.11/09/2023
1:23-cv-05352LockettAbbott Laboratories, Inc. et al
1:23-cv-05356GarciaAbbott Laboratories, Inc.
1:23-cv-05358GrantAbbott Laboratories, Inc
1:23-cv-05359PinoMead Johnson & Company, LLC
1:23-cv-05364MatthewAbbott Laboratories, Inc.
1:23-cv-05367NievesMead Johnson & Company, LLC
1:23-cv-05370StidmanAbbott Laboratories, Inc.
1:23-cv-05374YoungAbbott Laboratories, Inc.11/09/2023
1:23-cv-05381TompkinsAbbott Laboratories, Inc.11/09/2023
1:23-cv-05387SarteAbbott Laboratories, Inc11/09/2023
1:23-cv-05393EdwardsAbbott Laboratories, Inc.11/09/2023
1:23-cv-05396PurdoskiAbbott Laboratories, Inc
1:23-cv-05400VelmerAbbott Laboratories, Inc11/09/2023
1:23-cv-05403Jones-JohnsonAbbott Laboratories, Inc
1:23-cv-05404MiltonAbbott Laboratories, Inc11/09/2023
1:23-cv-05522PaytonAbbott Laboratories Inc
1:23-cv-05552DeloachAbbott Laboratories
1:23-cv-05653RoweAbbott Laboratories
1:23-cv-05663StrangeAbbott Laboratories
1:23-cv-05779WatersAbbott Laboratories
1:23-cv-05789Hamilton-KeithStrength of Nature, LLC
1:23-cv-05799LottererAbbott Laboratories
1:23-cv-05816EsquivelAbbott Laboratories
1:23-cv-05848WilliamsAbbott Laboratories, Inc.
1:23-cv-05865M.B.Abbott Laboratories
1:23-cv-05880MiddletonMead Johnson & Company
1:23-cv-05929GrayAbbott Laboratories Inc
1:23-cv-06103VosburghAbbott Laboratories
1:23-cv-06125CapelesAbbott Laboratories CT
1:23-cv-06390PopeAbbott Laboratories Inc.
1:23-cv-06690RobyAbbott Laboratories, Inc.
1:23-cv-06718NelsonAbbott Laboratories
1:23-cv-06719AtkinsonMead Johnson & Company, LLC
1:23-cv-06740SpikbergAbbott Laboratories
1:23-cv-06744ReyesAbbottt Laboratories
1:23-cv-06776ScheibelhutMead Johnson & Company
1:23-cv-06786ValentineRevlon Consumer Products Corporation
1:23-cv-06796DowningAbbott Laboratories
1:23-cv-06817MulqueenAbbott Laboratories
1:23-cv-06821JackowskiAbbott Laboratories
1:23-cv-06832GeorgeAbbott Laboratories
1:23-cv-07089SimsAbbott Laboratories, Inc.
1:23-cv-07487GarciaAbbott Laboratories
1:23-cv-07705McNealMead Johnson & Company, LLC
1:23-cv-13791HarrisMead Johnson & Company, LLC
1:23-cv-13875DavisMead Johnson & Company, LLC et al
1:23-cv-13889BrooksAbbott Laboratories, Inc.
1:23-cv-13924ConoverMead Johnson & Company, LLC et al
1:23-cv-13939I.C.Abbott Laboratories
1:23-cv-13947DrevonAbbott Laboratories
1:23-cv-14011BurkhartAbbott Laboratories
1:23-cv-14081JensenAbbott Laboratories
1:23-cv-14086MaysAbbott Laboratories
1:23-cv-14091AndersonAbbott Laboratories
1:23-cv-14126FranconeMead Johnson & Company, LLC
1:23-cv-14245HernandezAbbott Laboratories
1:23-cv-14454DuffAbbott Laboratories Inc
1:23-cv-14503ClayAbbott Laboratories
1:23-cv-14527GreenAbbott Laboratories
1:23-cv-14538Ladonya NewmanAbbott Laboratories
1:23-cv-14569RamosMead Johnson & Company, LLC
1:23-cv-14620MooneyAbbott Laboratories, Inc.
1:23-cv-14698SladeMead Johnson & Company, LLC
1:23-cv-14702BriggsAbbott Laboratories
1:23-cv-14859HamAbbott Laboratories
1:23-cv-14892MackAbbott Laboratories
1:23-cv-14958ThomasAbbott Laboratories Inc
1:23-cv-15117JacksonAbbott Laboratories, Inc.
1:23-cv-15204WilliamsAbbott Laboratories, Inc.
1:23-cv-15308OushanAbbott Laboratories
1:23-cv-15386HazenAbbott Laboratories Inc
1:23-cv-15441McLainAbbott Laboratories
1:23-cv-15454DavisAbbott Laboratories
1:23-cv-15459DobbsAbbott Laboratories
1:23-cv-15470HallAbbott Laboratories
1:23-cv-15472BarcakAbbott Laboratories
1:23-cv-15479LarsenAbbott Laboratories
1:23-cv-15508FarnsworthAbbott Laboratories
1:23-cv-15530TrotterAbbott Laboratories
1:23-cv-15537EcholsAbbott Laboratories
1:23-cv-15552YoungAbbott Laboratories
1:23-cv-15566NicholsonMead Johnson & Company, LLC
1:23-cv-15568JohnsonAbbott Laboratories
1:23-cv-15608FieldsMead Johnson & Company LLC
1:23-cv-15657SAMBRANOAbbott Laboratories, Inc.
1:23-cv-15659Flowers-MillerAbbott Laboratories, Inc.
1:23-cv-15660GardnerAbbott Laboratories, Inc.
1:23-cv-15685WalkerAbbott Laboratories
1:23-cv-15692N.T., by and through her natural mother and guardiAbbott Laboratories
1:23-cv-15719PayneAbbott Laboratories
1:23-cv-15740ButlerAbbott Laboratories
1:23-cv-15899R.S., by and through his natural mother and guardiMEAD JOHNSON & COMPANY, LLC
1:23-cv-15919RamirezAbbott Laboratories
1:23-cv-15922FountainMEAD JOHNSON & COMPANY, LLC
1:23-cv-15927YoungAbbott Laboratories
1:23-cv-15933LopezAbbott Laboratories
1:23-cv-15950GriffinAbbott Laboratories
1:23-cv-15954HernandezAbbott Laboratories
1:23-cv-16031CollinsAbbott Laboratories
1:23-cv-16033DoyenAbbott Laboratories
1:23-cv-16034KellyAbbott Laboratories
1:23-cv-16036KingAbbott Laboratories
1:23-cv-16037StedmanAbbott Laboratories
1:23-cv-16041WrightAbbott Laboratories
1:23-cv-16052BrownMead Johnson & Company, LLC
1:23-cv-16065CaseyAbbott Laboratories
1:23-cv-16092LiechtyAbbott Laboratories, Inc.
1:23-cv-16143Tims-BrownAbbott Laboratories
1:23-cv-16159CistrunkAbbott Laboratories
1:23-cv-16202MooreAbbott Laboratories, Inc.
1:23-cv-16360CoppernollAbbott Laboratories
1:23-cv-16389JohnsonMead Johnson & Company, LLC
1:23-cv-16415HintzMead Johnson & Company, LLC
1:23-cv-16420HenryAbbott Laboratories
1:23-cv-16430FolkMead Johnson & Company, LLC
1:23-cv-16517RoweAbbott Laboratories Inc.


 Case Management Orders

idDate PostedDoc.#Description
204/26/202234CASE MANAGEMENT ORDER NO. 1 Signed by the Honorable Rebecca R. Pallmeyer on 4/26/2022. Mailed notice(mjc, ) (Entered: 04/26/2022)
305/20/2022100MINUTE entry before the Honorable Rebecca R. Pallmeyer: Video Status hearing held on 5/19/2022. The court will rule promptly on competing proposals for designation of Lead and Liaison counsel and expects, as well, to set up a webpage for this MDL on the Court's website. A further status hearing is set for 6/30/22 at 10:00 a.m. to take place in person at the U. S. District Court, 219 South Dearborn, Chicago IL 60604. The parties will submit proposals regarding pretrial procedures, identifying disagreements, if any, no later than 6./17/2022. The court anticipates prompt consideration of pending motions for remand of removed cases. Mailed notice (mjc, ) (Entered: 05/20/2022)
406/02/2022109CASE MANAGEMENT ORDER NO. 2. Signed by the Honorable Rebecca R. Pallmeyer on 5/26/2022. Mailed notice(mjc, ) (Entered: 05/26/2022)
508/10/2022172CASE MANAGEMENT ORDER NO. 3: Disputes Regarding Privilege Order, Protective Order, and Master Complaint: Signed by the Honorable Rebecca R. Pallmeyer on 8/10/2022. Mailed notice. (cp, ) (Entered: 08/10/2022)
608/18/2022187CASE MANAGEMENT ORDER NO. 4, Rule 502(d) and Privileged Materials Order: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/18/2022)
708/18/2022188CASE MANAGEMENT ORDER NO. 5, STIPULATED PROTECTIVE ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/18/2022)
808/18/2022189CASE MANAGEMENT ORDER NO. 6, AGREED JOINT COORDINATION ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/18/2022)
908/18/2022190CASE MANAGEMENT ORDER NO. 7, Protocol for Selection of Initial Bellwether Discovery Cases and Initial Bellwether Trial Cases, and Authorization of Plaintiff Profile Forms: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/19/2022)
1008/25/2022200CASE MANAGEMENT ORDER NO. 8: COMMON BENEFIT ORDER TIMEKEEPING AND EXPENSES PROTOCOL: Signed by the Honorable Rebecca R. Pallmeyer on 8/25/2022. Mailed notice. (cp, ) (Entered: 08/25/2022)
1308/26/2022204ORDER on Request for Master Complaint: Signed by the Honorable Rebecca R. Pallmeyer on 8/26/2022. Mailed notice. (cp, ) (Entered: 08/26/2022)
1109/07/2022210AMENDED CASE MANAGEMENT ORDER NO. 7: Protocol for Selection of Initial Bellwether Discovery Cases and Initial Bellwether Trial Cases, and Authorization of Plaintiff Profile Forms. Signed by the Honorable Rebecca R. Pallmeyer on 9/7/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D) Mailed notice. (cp, ) (Entered: 09/08/2022)
1209/07/2022211CASE MANAGEMENT ORDER NO. 9: Jurisdictional Discovery and Briefing Schedule. Signed by the Honorable Rebecca R. Pallmeyer on 9/7/2022. Mailed notice. (cp, ) (Entered: 09/08/2022)
1409/27/2022232AMENDED CASE MANAGEMENT ORDER NO. 8: COMMON BENEFIT ORDER Timekeeping and Expenses Protocol: Signed by the Honorable Rebecca R. Pallmeyer on 9/27/2022. Mailed notice. (Attachments: # 1 Exhibit Monthly Time Report, # 2 Exhibit Monthly Time Report Totals, # 3 Exhibit Expense Report, # 4 Exhibit Supplemental Expense Report, # 5 Exhibit NEC Participation Agreement)(cp, ) (Entered: 09/27/2022)
1510/22/2022266MINUTE entry before the Honorable Rebecca R. Pallmeyer: Oral argument on Defendants' motion for scientific presentations 239 and Defendants' motion to compel 261 are set for 11/4/2022 at 11:00 a.m. via Webex video conference. Counsel of record will receive an email invitation prior to the start of the video. Members of the public and media will be able to call in to listen to this hearing. The call in number is: 650-479-3207 and access code is: 2316 722 9487. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice. (cp, ) (Entered: 10/20/2022)
1710/26/2022268THE PARTIES' JOINT STIPULATED ORDER regarding the protocol for producing documents and electronically stored information ("ESI"): Signed by the Honorable Rebecca R. Pallmeyer on 10/26/2022. Mailed notice. (cp, ) (Entered: 10/27/2022)
1611/03/2022274CASE MANAGEMENT ORDER NO. 10 APPROVING PLAINTIFF FACT SHEET: Signed by the Honorable Rebecca R. Pallmeyer on 11/3/2022. Mailed notice. (cp, ) (Entered: 11/03/2022)
1811/22/2022281ORDER signed by the Honorable Rebecca R. Pallmeyer on 11/22/2022: In its November 11, 2022 order, this court provided guidance with respect to the parties' disputes regarding a discovery schedule and directed them to make a further attempt to agree on a proposed schedule. Counsel report that their effort to reach accord was unsuccessful. For reasons explained earlier, the court concludes that the schedule proposed by the Plaintiffs' Leadership Committee is reasonably aggressive, and hereby adopts that schedule as set forth in the attached Order. This schedule is subject to adjustment only for good cause shown or by good faith agreement of counsel. Counsel are encouraged to continue efforts to coordinate the schedule in this MDL with schedule[s] set by state court judges. A further status hearing is set for December 13, 2022, as previously ordered. Lead counsel are again invited to advise the courtroom deputy whether an in-person proceeding, or a meeting by video platform, is preferable.
1912/01/2022282ORDER PURSUANT TO CMO 7 Identifying Initial Bellwether Discovery Cases Selected By Defendants: Signed by the Honorable Rebecca R. Pallmeyer on 12/1/2022. Mailed notice. (cp, ) (Entered: 12/01/2022)
2001/06/202329501/06/2023 295 ORDER: Pursuant to stipulation of the Plaintiffs' Leadership Committee and Counsel for Defendants 294 , the January 9, 2023 status date is stricken, and a further case schedule is established as set forth below. The court will conduct a further status hearing on February 1, 2023 at 9:00 a.m. Central Standard Time. The court will conduct a Science Day hearing beginning at 9:30 a.m. Central Standard Time on March 8, 2023. See attached Order for further details. Signed by the Honorable Rebecca R. Pallmeyer on 1/6/2023. Mailed notice. (cp, ) (Entered: 01/06/2023)
2101/06/2023296CASE MANAGEMENT ORDER NO. 11 - DIRECT FILING ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 1/6/2023. Mailed notice. (cp, ) (Entered: 01/06/2023)
2209/12/2023399AGREED ORDER for the release of pathology and stipulated pathology protocol: Signed by the Honorable Rebecca R. Pallmeyer on 9/12/2023. Mailed notice. (cp, ) (Entered: 09/12/2023)
2310/16/2023409STIPULATION AND ORDER to Extend Submission of Trial Selection Position Papers: Signed by the Honorable Rebecca R. Pallmeyer on 10/16/2023. Mailed notice. (cp, ) (Entered: 10/16/2023)
2411/03/2023419ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 11/3/2023. Mailed notice. (cp, ) (Entered: 11/03/2023)
2512/04/2023436REVISED SCHEDULING ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 12/4/2023. Mailed notice. (cp, ) (Entered: 12/04/2023)


 Status Conference Agendas

05/11/2022 67 ORDER SETTING AGENDA FOR MAY 12, 2022 STATUS CONFERENCE Signed by the Honorable Rebecca R. Pallmeyer on 5/11/2022.
06/30/2022 144 Proposed Agenda by Rebecca Donaldson, Shannon E. Hall (Debrosse Zimmermann, Diandra) (Entered: 06/30/2022)
08/17/2022 181 Proposed Agenda for August 18, 2022 Status Hearing by Abbott Laboratories (Parker, Stephanie) (Entered: 08/17/2022)
10/07/2022 245 Proposed Agenda for October 11, 2022 Status Hearing by Abbott Laboratories (Parker, Stephanie) (Entered: 10/07/2022)
12/12/2022 285 Proposed Agenda for December 13, 2022 Status Hearing by Abbott Laboratories (Parker, Stephanie) (Entered: 12/12/2022)
04/03/2023 342 Proposed Agenda for April 4, 2023 Status Hearing by Abbot Laboratories (Parker, Stephanie) (Entered: 04/03/2023)
As agreed by the parties, the next status hearing is set for 12/8/2023 at 1:30 p.m. The parties to contact the courtroom deputy to specify if this status hearing is to be conducted in person or by video platform.


 WebEx Access and Telephone Hearing Information

WebEx Access Information

WebEx, with a call-in number of 1-650-479-3207 and access code 23040381197. To join the conference by WebEx video, counsel of record and members of the public can join by clicking on the following hyperlink:

https://us-courts.webex.com/us-courts/j.php?MTID=m9b0894a49d7c2638b2eecbe6320489fa.

Telephone Hearing Access Information

Please click on the below hyperlink  to take you to Judge Pallmeyer's telephone conference login. From there, join conference As Guest, Enter your name, Type the digits in the picture, Click on the Call Me option and fill in your phone number and name.  You will receive a call and be connected to the conference line. While participants will have the ability to identify who is speaking, speakers should still identify themselves for the purpose of creating a clear record. Participants should be careful to speak clearly and not to speak over any other participants.  If you do not have access to a computer Dial: TELEPHONE NUMBER.

Click here to join the conference: https://teleconference.uc.att.com/ecm/?bp=6366510008&mac=6708061

If the above link does not work, please call: (877)336-1839 or (636)651-0008, access and security code: 6708061#.



 Upcoming Court Proceedings

06/21/2023

view 368

MINUTE entry before the Honorable Rebecca R. Pallmeyer: Telephone status hearing held. The proposed revised schedule motion 365 is entered and continued. The parties are encouraged promptly to bring to the court's attention discovery problems that can threaten cooperative progress. For the reasons stated on the record, this matter is continued to a status hearing on 7/27/23 at 10:00 a.m. via Microsoft Teams Video Conferencing. The courtroom deputy will email a video link to the Attorneys who will be participating in the hearing. Members of the public and media will be able to call in to listen to this hearing. The call in number is: 312-646-0998 and the access code is: 527 806 030#. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice. (cp, ) (Entered: 06/23/2023)
07/26/2023

382

MINUTE entry before the Honorable Rebecca R. Pallmeyer: As agreed by the parties, the video status hearing set for 7/27/2023 is stricken to be re-set at a later time.
08/17/2023

388

MINUTE entry before the Honorable Rebecca R. Pallmeyer: On the court's own motion and by agreement of the parties, the next status hearing is set for 9/8/2023 at 1:30 via Microsoft Teams Video Conferencing. The courtroom deputy will email a video link to the Attorneys who will be participating in the hearing. Members of the public and media will be able to call in to listen to this hearing. The call in number is: 312-646-0998 and the access code is: 272 150 167#. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court.






Load Data...
Close
Load Data...
Close
Load Data...
Close
Load Data...
Close